Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 4/20 | 0.43 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.42 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | FNTA | P49354 | 1/20 | 0.40 |
| ▸ | FNTB | P49356 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL607091 | 1.00 | SLC7A5 (0.55) | SLC7A5CA2CAMK2AESR1ESR2 | |
| SCHEMBL7276725 | 0.91 | SLC7A5 (0.46) | SLC7A5ESR1ESR2 | |
| SCHEMBL23610302 | 0.86 | SLC7A5 (0.51) | SLC7A5CA2CAMK2AESR1ESR2 | |
| SCHEMBL11053244 | 0.86 | SLC7A5 (0.51) | SLC7A5CA2CAMK2AESR1ESR2 | |
| SCHEMBL11053246 | 0.86 | SLC7A5 (0.51) | SLC7A5CA2CAMK2AESR1ESR2 | |
| SCHEMBL1573822 | 0.85 | CYP1A2 (0.55) | SLC7A5FOLH1 | |
| SCHEMBL3724926 | 0.85 | CYP1A2 (0.55) | SLC7A5FOLH1 | |
| SCHEMBL296747 | 0.85 | CYP1A2 (0.55) | SLC7A5FOLH1 | |
| SCHEMBL2542276 | 0.83 | SLC7A5 (0.56) | SLC7A5CA2CAMK2AESR1ESR2 | |
| SCHEMBL2986794 | 0.83 | SLC7A5 (0.56) | SLC7A5CA2CAMK2AESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109988312-B | Polyamide acid ester, preparation method, negative polyimide composition and application | 深圳先进技术研究院 | 2023-04-11 | — | — | CN | claimed |
| CN-109988312-A | A kind of poly amic acid ester, preparation method and negative polyimide composition and application | 深圳先进技术研究院 | 2019-07-09 | — | — | CN | claimed |
| CN-109946925-A | A kind of compound is promoting the application in polyimides low-temperature setting, polyimide precursor composition and application thereof | 深圳先进技术研究院 | 2019-06-28 | — | — | CN | claimed |
| EP-1856274-B1 | SYSTEMIC MARKERS FOR ASTHMA AND ANALOGOUS DISEASES | CLEVELAND CLINIC FOUNDATION (US) | 2014-08-27 | — | — | EP | claimed |
| US-20110165594-A1 | SYSTEMIC MARKERS FOR ASTHMA AND ANALOGOUS DISEASES | THE CLEVELAND CLINIC FOUNDATION (US) | 2011-07-07 | — | — | US | claimed |
| EP-1856274-A2 | SYSTEMIC MARKERS FOR ASTHMA AND ANALOGOUS DISEASES | THE CLEVELAND CLINIC FOUNDATION (US) | 2007-11-21 | — | — | EP | claimed |
| US-20060211079-A1 | Systemic markers for asthma and analogous diseases | THE CLEVELAND CLINIC FOUNDATION | 2006-09-21 | — | — | US | claimed |
| WO-2006091403-A2 | SYSTEMIC MARKERS FOR ASTHMA AND ANALOGOUS DISEASES | THE CLEVELAND CLINIC FOUNDATION (US) | 2006-08-31 | — | — | WO | claimed |
| US-5756650-A | COMPOSITION COMPRISING POLYAMIC ACID, CURE ACCELERATOR SELECTED FROM GROUP CONSISTING OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, AMINO ACID COMPOUND, AROMATIC COMPOUND HAVING TWO OR MORE HYDROXYL GROUPS | KABUSHIKI KAISHA TOSHIBA (JP) | 1998-05-26 | — | — | US | claimed |
| US-12084614-B2 | Akaline scale mitigation treatment method | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-09-10 | — | — | US | disclosed |
| US-12084613-B2 | Oil/gas pipeline treatment method | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-09-10 | — | — | US | disclosed |
| US-12031086-B1 | Well sulfatizing and scale mitigation treatment method | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-07-09 | — | — | US | disclosed |
| US-20240218237-A1 | WELL SULFATIZING AND SCALE MITIGATION TREATMENT METHOD | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-07-04 | — | — | US | disclosed |
| US-20240218236-A1 | OIL/GAS PIPELINE TREATMENT METHOD | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-07-04 | — | — | US | disclosed |
| US-20060024724-A1 | Oncofetal fibronectin as a marker for health and disease | CYTYC SURGICAL PRODUCTS II LIMITED PARTNERSHIP | 2006-02-02 | — | — | US | disclosed |
| US-20060024725-A1 | Oncofetal fibronectin as a marker for pregnancy-related indications | THIRD WAVE TECHNOLOGIES, INC. | 2006-02-02 | — | — | US | disclosed |
| US-20060024757-A1 | Detection of oncofetal fibronectin for selection of concepti | CYTYC SURGICAL PRODUCTS II LIMITED PARTNERSHIP | 2006-02-02 | — | — | US | disclosed |
| US-20060024722-A1 | Samples for detection of oncofetal fibronectin and uses thereof | BIOLUCENT, LLC | 2006-02-02 | — | — | US | disclosed |
| US-20060024723-A1 | Methods for detecting oncofetal fibronectin | CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP | 2006-02-02 | — | — | US | disclosed |
| US-5756650-A | COMPOSITION COMPRISING POLYAMIC ACID, CURE ACCELERATOR SELECTED FROM GROUP CONSISTING OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, AMINO ACID COMPOUND, AROMATIC COMPOUND HAVING TWO OR MORE HYDROXYL GROUPS | KABUSHIKI KAISHA TOSHIBA (JP) | 1998-05-26 | — | — | US | disclosed |